Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105

Darcy Bates, Edmond J. Feris, Alexey Danilov, Alan Eastman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Microtubule targeting agents, such as vinblastine, are usually thought to arrest cells in mitosis and subsequently induce apoptosis. However, they can also cause rapid induction of apoptosis in a cell-cycle phase independent manner. BNC105 is a novel vascular and microtubule disrupting drug that also induces apoptosis rapidly but with markedly increased potency compared to vinca alkaloids and combretastatin A4. BNC105 binds to the colchicine-binding site on tubulin resulting in activation of c-Jun N-terminal kinase (JNK), phosphorylation of ATF2, and induction of ATF3 and Noxa leading to acute apoptosis in chronic lymphocytic leukemia (CLL) cells. Apoptosis induced by BNC105 is dependent upon both JNK activation and Noxa induction. Normal leukocytes and one CLL sample also exhibited JNK activation but not Noxa induction and were resistant to BNC105. This study emphasizes the importance of Noxa and JNK for induction of apoptosis in CLL cells by microtubule targeting drugs, and highlights the potential of BNC105 as a potent therapeutic to treat haematopoietic malignancies.

Original languageEnglish (US)
Pages (from-to)1-9
Number of pages9
JournalCancer Biology and Therapy
DOIs
StateAccepted/In press - Feb 11 2016

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Noxae
Microtubules
JNK Mitogen-Activated Protein Kinases
Apoptosis
Vinca Alkaloids
Vinblastine
Colchicine
Hematologic Neoplasms
Drug Delivery Systems
Tubulin
Mitosis
Blood Vessels
BNC 105
Cell Cycle
Leukocytes
Binding Sites
Phosphorylation
Pharmaceutical Preparations

Keywords

  • Apoptosis
  • BNC105
  • c-Jun N-terminal kinase
  • chronic lymphocytic leukemia
  • Noxa

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105. / Bates, Darcy; Feris, Edmond J.; Danilov, Alexey; Eastman, Alan.

In: Cancer Biology and Therapy, 11.02.2016, p. 1-9.

Research output: Contribution to journalArticle

@article{b0d0087a8f2441888f15b90659def0b1,
title = "Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105",
abstract = "Microtubule targeting agents, such as vinblastine, are usually thought to arrest cells in mitosis and subsequently induce apoptosis. However, they can also cause rapid induction of apoptosis in a cell-cycle phase independent manner. BNC105 is a novel vascular and microtubule disrupting drug that also induces apoptosis rapidly but with markedly increased potency compared to vinca alkaloids and combretastatin A4. BNC105 binds to the colchicine-binding site on tubulin resulting in activation of c-Jun N-terminal kinase (JNK), phosphorylation of ATF2, and induction of ATF3 and Noxa leading to acute apoptosis in chronic lymphocytic leukemia (CLL) cells. Apoptosis induced by BNC105 is dependent upon both JNK activation and Noxa induction. Normal leukocytes and one CLL sample also exhibited JNK activation but not Noxa induction and were resistant to BNC105. This study emphasizes the importance of Noxa and JNK for induction of apoptosis in CLL cells by microtubule targeting drugs, and highlights the potential of BNC105 as a potent therapeutic to treat haematopoietic malignancies.",
keywords = "Apoptosis, BNC105, c-Jun N-terminal kinase, chronic lymphocytic leukemia, Noxa",
author = "Darcy Bates and Feris, {Edmond J.} and Alexey Danilov and Alan Eastman",
year = "2016",
month = "2",
day = "11",
doi = "10.1080/15384047.2016.1139245",
language = "English (US)",
pages = "1--9",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - Rapid induction of apoptosis in chronic lymphocytic leukemia cells by the microtubule disrupting agent BNC105

AU - Bates, Darcy

AU - Feris, Edmond J.

AU - Danilov, Alexey

AU - Eastman, Alan

PY - 2016/2/11

Y1 - 2016/2/11

N2 - Microtubule targeting agents, such as vinblastine, are usually thought to arrest cells in mitosis and subsequently induce apoptosis. However, they can also cause rapid induction of apoptosis in a cell-cycle phase independent manner. BNC105 is a novel vascular and microtubule disrupting drug that also induces apoptosis rapidly but with markedly increased potency compared to vinca alkaloids and combretastatin A4. BNC105 binds to the colchicine-binding site on tubulin resulting in activation of c-Jun N-terminal kinase (JNK), phosphorylation of ATF2, and induction of ATF3 and Noxa leading to acute apoptosis in chronic lymphocytic leukemia (CLL) cells. Apoptosis induced by BNC105 is dependent upon both JNK activation and Noxa induction. Normal leukocytes and one CLL sample also exhibited JNK activation but not Noxa induction and were resistant to BNC105. This study emphasizes the importance of Noxa and JNK for induction of apoptosis in CLL cells by microtubule targeting drugs, and highlights the potential of BNC105 as a potent therapeutic to treat haematopoietic malignancies.

AB - Microtubule targeting agents, such as vinblastine, are usually thought to arrest cells in mitosis and subsequently induce apoptosis. However, they can also cause rapid induction of apoptosis in a cell-cycle phase independent manner. BNC105 is a novel vascular and microtubule disrupting drug that also induces apoptosis rapidly but with markedly increased potency compared to vinca alkaloids and combretastatin A4. BNC105 binds to the colchicine-binding site on tubulin resulting in activation of c-Jun N-terminal kinase (JNK), phosphorylation of ATF2, and induction of ATF3 and Noxa leading to acute apoptosis in chronic lymphocytic leukemia (CLL) cells. Apoptosis induced by BNC105 is dependent upon both JNK activation and Noxa induction. Normal leukocytes and one CLL sample also exhibited JNK activation but not Noxa induction and were resistant to BNC105. This study emphasizes the importance of Noxa and JNK for induction of apoptosis in CLL cells by microtubule targeting drugs, and highlights the potential of BNC105 as a potent therapeutic to treat haematopoietic malignancies.

KW - Apoptosis

KW - BNC105

KW - c-Jun N-terminal kinase

KW - chronic lymphocytic leukemia

KW - Noxa

UR - http://www.scopus.com/inward/record.url?scp=84958761677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958761677&partnerID=8YFLogxK

U2 - 10.1080/15384047.2016.1139245

DO - 10.1080/15384047.2016.1139245

M3 - Article

SP - 1

EP - 9

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

ER -